At Nouvogenes Therapeutics, we are driven by a bold vision: to transform the treatment of chronic diseases through precision gene editing. Using cutting-edge CRISPR technology, our clinical-stage therapies target the root cause of conditions, offering not just incremental improvements, but the possi...See more
Headquarters:
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2025 (1 years)
Address:
null
LOW
spending power